Chloral betaine

Last updated
Chloral betaine
Chloral betaine.svg
Clinical data
Routes of
administration 		Oral
ATC code
  • None
Legal status
Legal status
Identifiers
  • 2,2,2-Trichloro-1,1-ethanediol : (trimethylammonio)acetate (1:1)
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.017.021 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C7H14Cl3NO4
Molar mass 282.54 g·mol−1
3D model (JSmol)
  • C[N+](C)(C)CC(=O)[O-].C(C(Cl)(Cl)Cl)(O)O
  • InChI=1S/C5H11NO2.C2H3Cl3O2/c1-6(2,3)4-5(7)8;3-2(4,5)1(6)7/h4H2,1-3H3;1,6-7H
  • Key:ONAOIDNSINNZOA-UHFFFAOYSA-N

Chloral betaine (USAN, BAN) (brand names Beta-Chlor, Somilan), also known as cloral betaine (INN), is a sedative-hypnotic drug. [1] [2] [3] [4] It was introduced by Mead Johnson in the United States in 1963. [5] It is a betaine complex with chloral hydrate, which acts as an extended-acting formulation of chloral hydrate which is then metabolized into trichloroethanol, which is responsible for most or all of its effects. [3] [4] [6]

See also

Related Research Articles

<span class="mw-page-title-main">Chloral hydrate</span> Chemical sedative and hypnotic drug

Chloral hydrate is a geminal diol with the formula C2H3Cl3O2. It is a colorless solid. It has limited use as a sedative and hypnotic pharmaceutical drug. It is also a useful laboratory chemical reagent and precursor. It is derived from chloral (trichloroacetaldehyde) by the addition of one equivalent of water.

<span class="mw-page-title-main">Fluorometholone</span> Chemical compound

Fluorometholone, also known as 6α-methyl-9α-fluoro-11β,17α-dihydroxypregna-1,4-diene-3,20-dione, is a synthetic glucocorticoid which is used in the treatment of inflammatory eye diseases. The C17α acetate ester, fluorometholone acetate, is also a glucocorticoid and is used for similar indications.

<span class="mw-page-title-main">Canrenoic acid</span> Chemical compound

Canrenoic acid is a synthetic steroidal antimineralocorticoid which was never marketed.

<span class="mw-page-title-main">Prednimustine</span> Chemical compound

Prednimustine, sold under the brand names Mostarina and Sterecyst, is a medication which is used in chemotherapy in the treatment of leukemias and lymphomas. It is the ester formed from two other drugs, prednisolone and chlorambucil. Rarely, it has been associated with myoclonus.

<span class="mw-page-title-main">Chlorproethazine</span> Chemical compound

Chlorproethazine, sold under the brand name Neuriplege, is a drug of the phenothiazine group described as a muscle relaxant or tranquilizer which is or has been marketed in Europe as a topical cream for the treatment of muscle pain. It has been associated with photoallergic contact dermatitis.

<span class="mw-page-title-main">Oxabolone</span> Chemical compound

Oxabolone is a synthetic anabolic-androgenic steroid (AAS) of the nandrolone (19-nortestosterone) group which was never marketed. It can be formulated as the cipionate ester prodrug oxabolone cipionate, which, in contrast, has been marketed for medical use.

<span class="mw-page-title-main">Butidrine</span> Chemical compound

Butidrine (INN), or butedrine or butydrine, also known as hydrobutamine or idrobutamine, is a beta blocker related to pronethalol and propranolol that was developed in the 1960s. Similarly to certain other beta blockers, butidrine also possesses local anesthetic properties.

<span class="mw-page-title-main">Zoxazolamine</span> Chemical compound

Zoxazolamine is a muscle relaxant that is no longer marketed. It was synthesized in 1953 and introduced clinically in 1955 but was withdrawn due to hepatotoxicity. One of its active metabolites, chlorzoxazone, was found to show less toxicity, and was subsequently marketed in place of zoxazolamine. These drugs activate IKCa channels.

<span class="mw-page-title-main">Testosterone isocaproate</span> Chemical compound

Testosterone isocaproate, sold under the brand names Sustanon 100, Sustanon 250, and Omnadren 250, is an androgen and anabolic steroid medication and a testosterone ester which has been used as a component of mixed testosterone ester preparations.

<span class="mw-page-title-main">Hexestrol</span> Chemical compound

Hexestrol, sold under the brand name Synestrol among others, is a nonsteroidal estrogen which was previously used for estrogen replacement therapy and in the treatment of certain hormone-dependent cancers as well as gynecological disorders but is mostly no longer marketed. It has also been used in the form of esters such as hexestrol diacetate and hexestrol dipropionate. Hexestrol and its esters are taken by mouth, held under the tongue, or via injection into muscle.

<span class="mw-page-title-main">Methestrol</span> Chemical compound

Methestrol or methoestrol, also known as promethestrol or promethoestrol (BAN) or as dimethylhexestrol, is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol which is no longer marketed.

<span class="mw-page-title-main">Methestrol dipropionate</span> Chemical compound

Methestrol dipropionate or methoestrol dipropionate, also known as promethestrol dipropionate or promethoestrol dipropionate or as dimethylhexestrol dipropionate, is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that is or was used clinically. It is the dipropionate form of methestrol, which, in contrast to methestrol dipropionate, was never marketed.

<span class="mw-page-title-main">Algestone acetonide</span> Chemical compound

Algestone acetonide, also known as algestone 16α,17α-acetonide or 16α,17α-isopropylidenedioxyprogesterone, is a progestin which was never marketed. It is the acetonide cyclic ketal of algestone. Another progestin, algestone acetophenide, in contrast, has been marketed.

<span class="mw-page-title-main">Androstenediol dipropionate</span> Chemical compound

Androstenediol dipropionate, or 5-androstenediol 3β,17β-dipropionate, also known as androst-5-ene-3β,17β-diol 3β,17β-dipropionate, is a synthetic anabolic–androgenic steroid and an androgen ester – specifically, the dipropionate diester of 5-androstenediol (androst-5-ene-3β,17β-diol) – which has been marketed in Europe, including in Spain, Italy, and Austria.

Ovandrotone albumin, also known as polyandroalbumin, as well as ovandrotone:human serum albumin conjugate, is an immunogen and vaccine against androstenedione that is used in veterinary medicine to increase the ovulation rate and number of lambs born to ewes. It is a conjugate of ovandrotone (androstenedione-7α-carboxyethylthioether) and human serum albumin. The drug was developed by 1981 and was introduced in Australia and New Zealand in 1983.

<span class="mw-page-title-main">Panomifene</span> Chemical compound

Panomifene is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group related to tamoxifen that was under development as an antineoplastic agent by Egis Pharmaceuticals and IVAX Drug Research Institute in the 1990s for the treatment of breast cancer, but it was never marketed. It reached phase II clinical trials before development was terminated. The drug was described in 1981.

<span class="mw-page-title-main">Endrisone</span> Chemical compound

Endrisone (INN), or endrysone (USAN), is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI. It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively.

<span class="mw-page-title-main">Dacuronium bromide</span> Chemical compound

Dacuronium bromide is an aminosteroid neuromuscular blocking agent which was never marketed. It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR).

<span class="mw-page-title-main">Prorenoate potassium</span> Chemical compound

Prorenoate potassium is a synthetic steroidal antimineralocorticoid which was never marketed.

References

  1. ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1231–. ISBN   978-1-4757-2085-3.
  2. ↑ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 72–. ISBN   978-94-011-4439-1.
  3. 1 2 Bassuk EL, Schoonover SC, Gelenberg AJ (6 December 2012). The Practitioner's Guide to Psychoactive Drugs. Springer Science & Business Media. pp. 208–. ISBN   978-1-4615-8049-2.
  4. 1 2 Lowry W (6 December 2012). Forensic Toxicology: Controlled Substances and Dangerous Drugs. Springer Science & Business Media. pp. 157–. ISBN   978-1-4684-3444-6.
  5. ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 944–. ISBN   978-0-8155-1856-3.
  6. ↑ Maxwell GM (6 December 2012). Principles of Paediatric Pharmacology. Springer Science & Business Media. pp. 124–. ISBN   978-1-4684-7544-9.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.